We are live on
!
Find out more
SELLAS Life Sciences
28 hedge funds and large institutions have $4.54M invested in SELLAS Life Sciences in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
8,676% more call options, than puts
Call options by funds: $2.98M | Put options by funds: $34K
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
12% more funds holding
Funds holding: 25 → 28 (+3)
1.27% less ownership
Funds ownership: 11.03% → 9.76% (-1.3%)
8% less capital invested
Capital invested by funds: $4.91M → $4.54M (-$370K)
Holders
28
Holders Change
+3
Holders Change %
+12%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
6
Closed
2
Calls
$2.98M
Puts
$34K
Net Calls
+$2.95M
Net Calls Change
-$188K
Top Buyers
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$962K |
| 2 |
Morgan Stanley
New York
|
-$9.46K |
| 3 |
PFG
Prosperity Financial Group
San Ramon,
California
|
-$7.89K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.99K |
| 5 |
BlackRock
New York
|
-$4.37K |
